177 related articles for article (PubMed ID: 27889507)
1. CYP2C9 Genotypes Modify Benzodiazepine-Related Fall Risk: Original Results From Three Studies With Meta-Analysis.
Ham AC; Ziere G; Broer L; Swart KM; Enneman AW; van Dijk SC; van Wijngaarden JP; van der Zwaluw NL; Brouwer-Brolsma EM; Dhonukshe-Rutten RA; van Schoor NM; Zillikens MC; van Gelder T; de Vries OJ; Lips P; Deeg DJ; de Groot LC; Hofman A; Witkamp RF; Uitterlinden AG; Stricker BH; van der Velde N
J Am Med Dir Assoc; 2017 Jan; 18(1):88.e1-88.e15. PubMed ID: 27889507
[TBL] [Abstract][Full Text] [Related]
2. Medication-related fall incidents in an older, ambulant population: the B-PROOF study.
Ham AC; Swart KM; Enneman AW; van Dijk SC; Oliai Araghi S; van Wijngaarden JP; van der Zwaluw NL; Brouwer-Brolsma EM; Dhonukshe-Rutten RA; van Schoor NM; van der Cammen TJ; Lips P; de Groot LC; Uitterlinden AG; Witkamp RF; Stricker BH; van der Velde N
Drugs Aging; 2014 Dec; 31(12):917-27. PubMed ID: 25398701
[TBL] [Abstract][Full Text] [Related]
3. Beta-blocker use and fall risk in older individuals: Original results from two studies with meta-analysis.
Ham AC; van Dijk SC; Swart KMA; Enneman AW; van der Zwaluw NL; Brouwer-Brolsma EM; van Schoor NM; Zillikens MC; Lips P; de Groot LCPGM; Hofman A; Witkamp RF; Uitterlinden AG; Stricker BH; van der Velde N
Br J Clin Pharmacol; 2017 Oct; 83(10):2292-2302. PubMed ID: 28589543
[TBL] [Abstract][Full Text] [Related]
4. Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status.
Schalekamp T; Oosterhof M; van Meegen E; van Der Meer FJ; Conemans J; Hermans M; Meijerman I; de Boer A
Clin Pharmacol Ther; 2004 Nov; 76(5):409-17. PubMed ID: 15536456
[TBL] [Abstract][Full Text] [Related]
5. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users.
Tamblyn R; Abrahamowicz M; du Berger R; McLeod P; Bartlett G
J Am Geriatr Soc; 2005 Feb; 53(2):233-41. PubMed ID: 15673346
[TBL] [Abstract][Full Text] [Related]
6. Association between the CYP2C9 polymorphism and the drug metabolism phenotype.
Topić E; Stefanović M; Samardzija M
Clin Chem Lab Med; 2004 Jan; 42(1):72-8. PubMed ID: 15061384
[TBL] [Abstract][Full Text] [Related]
7. Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics.
Seppala LJ; Wermelink AMAT; de Vries M; Ploegmakers KJ; van de Glind EMM; Daams JG; van der Velde N;
J Am Med Dir Assoc; 2018 Apr; 19(4):371.e11-371.e17. PubMed ID: 29402652
[TBL] [Abstract][Full Text] [Related]
8. Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease.
Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S
CMAJ; 2017 Apr; 189(14):E519-E529. PubMed ID: 28396328
[TBL] [Abstract][Full Text] [Related]
9. Candidate genetic variants and antidepressant-related fall risk in middle-aged and older adults.
Pronk AC; Seppala LJ; Trajanoska K; Stringa N; van de Loo B; de Groot LCPGM; van Schoor NM; Koskeridis F; Markozannes G; Ntzani E; Uitterlinden AG; Rivadeneira F; Stricker BH; van der Velde N
PLoS One; 2022; 17(4):e0266590. PubMed ID: 35421149
[TBL] [Abstract][Full Text] [Related]
10. Assessing the cumulative effects of exposure to selected benzodiazepines on the risk of fall-related injuries in the elderly.
Sylvestre MP; Abrahamowicz M; Čapek R; Tamblyn R
Int Psychogeriatr; 2012 Apr; 24(4):577-86. PubMed ID: 22059800
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepines and injurious falls in community dwelling elders.
Pariente A; Dartigues JF; Benichou J; Letenneur L; Moore N; Fourrier-Réglat A
Drugs Aging; 2008; 25(1):61-70. PubMed ID: 18184030
[TBL] [Abstract][Full Text] [Related]
12. The elimination half-life of benzodiazepines and fall risk: two prospective observational studies.
de Vries OJ; Peeters G; Elders P; Sonnenberg C; Muller M; Deeg DJ; Lips P
Age Ageing; 2013 Nov; 42(6):764-70. PubMed ID: 23900130
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system-active medications and risk for falls in older women.
Ensrud KE; Blackwell TL; Mangione CM; Bowman PJ; Whooley MA; Bauer DC; Schwartz AV; Hanlon JT; Nevitt MC;
J Am Geriatr Soc; 2002 Oct; 50(10):1629-37. PubMed ID: 12366615
[TBL] [Abstract][Full Text] [Related]
14. The costs of benzodiazepine-associated hospital-treated fall Injuries in the EU: a Pharmo study.
Panneman MJ; Goettsch WG; Kramarz P; Herings RM
Drugs Aging; 2003; 20(11):833-9. PubMed ID: 12964889
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose Trazodone, Benzodiazepines, and Fall-Related Injuries in Nursing Homes: A Matched-Cohort Study.
Bronskill SE; Campitelli MA; Iaboni A; Herrmann N; Guan J; Maclagan LC; Watt J; Rochon PA; Morris AM; Jeffs L; Bell CM; Maxwell CJ
J Am Geriatr Soc; 2018 Oct; 66(10):1963-1971. PubMed ID: 30247773
[TBL] [Abstract][Full Text] [Related]
16. VKORC1 and CYP2C9 genotypes and phenprocoumon anticoagulation status: interaction between both genotypes affects dose requirement.
Schalekamp T; Brassé BP; Roijers JF; van Meegen E; van der Meer FJ; van Wijk EM; Egberts AC; de Boer A
Clin Pharmacol Ther; 2007 Feb; 81(2):185-93. PubMed ID: 17192772
[TBL] [Abstract][Full Text] [Related]
17. VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation.
Schalekamp T; Brassé BP; Roijers JF; Chahid Y; van Geest-Daalderop JH; de Vries-Goldschmeding H; van Wijk EM; Egberts AC; de Boer A
Clin Pharmacol Ther; 2006 Jul; 80(1):13-22. PubMed ID: 16815313
[TBL] [Abstract][Full Text] [Related]
18. Is the use of benzodiazepines associated with incident disability?
Gray SL; LaCroix AZ; Blough D; Wagner EH; Koepsell TD; Buchner D
J Am Geriatr Soc; 2002 Jun; 50(6):1012-8. PubMed ID: 12110059
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: a population-based study.
Hofe IV; Stricker BH; Vernooij MW; Ikram MK; Ikram MA; Wolters FJ
BMC Med; 2024 Jul; 22(1):266. PubMed ID: 38951846
[TBL] [Abstract][Full Text] [Related]
20. The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon.
Visser LE; van Schaik RH; van Vliet M; Trienekens PH; De Smet PA; Vulto AG; Hofman A; van Duijn CM; Stricker BH
Thromb Haemost; 2004 Jul; 92(1):61-6. PubMed ID: 15213846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
